Chip Parkinson

Myriad Genetics has appointed Chip Parkinson as executive vice president for reimbursement strategy. He will report to President and CEO Mark Capone. Parkinson comes to Myriad from Cambia Health Solutions where he served as president of OmedRx and MedSavvy, and as chief pharmacy officer for Regence Blue Cross Blue Shield Health Plans. He has also served in general management and managed care leadership roles at Pfizer and Myriad.


Jason Flowerday

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.